The Conundrum of Genetic "Drivers" in Benign Conditions

Advances in deep genomic sequencing have identified a spectrum of cancer-specific passenger and driver aberrations. Clones with driver anomalies are believed to be positively selected during carcinogenesis. Accumulating evidence, however, shows that genomic alterations, such as those inBRAF,RAS,EGFR...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute Jg. 108; H. 8
Hauptverfasser:	Kato, Shumei, Lippman, Scott M, Flaherty, Keith T, Kurzrock, Razelle
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.08.2016
Schlagworte:	Carcinogenesis - genetics Class I Phosphatidylinositol 3-Kinases Cyclin-Dependent Kinase Inhibitor p18 - genetics Gene Rearrangement GTP-Binding Protein alpha Subunits, Gq-G11 - genetics Humans Mutation Neoplasms - genetics Neoplasms - prevention & control Neurofibromin 1 - genetics Neurofibromin 2 - genetics Phosphatidylinositol 3-Kinases - genetics Precancerous Conditions - genetics Proto-Oncogene Proteins B-raf - genetics ras Proteins - genetics Receptor Protein-Tyrosine Kinases - genetics Receptor, ErbB-2 - genetics Receptor, Fibroblast Growth Factor, Type 3 - genetics Tumor Suppressor Protein p53 - genetics
ISSN:	1460-2105, 1460-2105
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!